Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BrainScope Company

Request full access

Brainscope, a health technology company, develops hand-held, non-invasive tools to assess the brain functions at the initial point of care

Bethesda, United StatesFounded 1990Health Tech & Medtech

About BrainScope Company

BrainScope is a pioneering medical neurotechnology company focused on improving brain health through advanced diagnostic tools. The company specializes in the objective assessment of brain injuries, particularly concussions and mild traumatic brain injuries (mTBIs). BrainScope's flagship product, the BrainScope One system, is a portable, FDA-cleared device that uses EEG (electroencephalogram) technology to provide quick, efficient, and accurate assessments without the need for radiation.

BrainScope primarily serves healthcare providers, including hospitals, urgent care centers, and sports medicine clinics. These clients benefit from the device's ability to deliver objective diagnostic insights, which can lead to better patient care and more informed treatment decisions. The company operates in the medical technology market, specifically within the niche of brain injury diagnostics.

The business model of BrainScope revolves around the sale and distribution of its BrainScope One system to healthcare institutions. Additionally, the company may generate revenue through service agreements, training programs, and ongoing support for its devices. By providing a reliable and efficient tool for brain injury assessment, BrainScope helps healthcare providers improve patient outcomes and streamline their diagnostic processes.

Recently, BrainScope has made significant strides in its commercial adoption, highlighted by the appointment of industry veteran Susan Hertzberg as CEO. The company has also achieved key milestones, such as surpassing primary endpoints in a multi-year Department of Defense-funded validation study for its new concussion assessment capability. These developments underscore BrainScope's commitment to advancing brain health and solidifying its position in the market.

Source: Dealroom company data

At a glance

Status
Operational
Employees
55
Open positions
2
Dealroom signal
28.0/100
Industry
Health
Sub-industry
Medical Devices
Sector
Biotechnology, Neurology, Brain, Non-Invasive medical devices and treatments, Medical Device, Health Diagnostics, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2C

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Sep 2023 $0 — Alzheimer's Drug Discovery Foundation ↗
DEBT✓Debt Oct 2021 $35M — Aon —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

BrainScope Company website traffic

Latest recorded traffic for BrainScope Company is 6.7K monthly website visits, up 168% over the last three months. BrainScope Company's team grew 0% over the past year.

Latest monthly visits6.7K 3-month web change+168% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BrainScope Company in the Bethesda ecosystem

Live from Dealroom

The BrainScope Company office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Maryland Venture Fund
  • Difference Capital
  • ZG Ventures
  • DBL Partners
  • Revolution
  • Alzheimer's Drug Discovery Foundation

Series B and later1 investor entered at this stage

  • Aon

Other known investors1 additional known investor

  • Ira Ehrenpreis.
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BrainScope Company on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BrainScope Company’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.